Arcus Biosciences Inc.
14.21
0.39 (2.82%)
At close: Jan 15, 2025, 11:49 AM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -4.6 -5.58 52.95 -12.19 -5.83 -7.52 -13.63 -23.23
PS Ratio 12.08 13.29 7.33 18.35 29.51 44.64 511.93 n/a
PB Ratio 3.06 2.27 3.34 2.83 2.70 1.59 4.70 4.20
P/FCF Ratio -4.28 3.50 -9.94 13.16 -5.87 -7.98 -23.66 -24.49
P/OCF Ratio -4.62 3.40 -10.96 12.79 -6.03 -8.67 -28.87 -32.25
OCF/S Ratio -2.62 3.91 -0.67 1.43 -4.9 -5.15 -17.73 n/a
Debt / Equity Ratio 0.02 0.18 0.14 0.03 n/a n/a n/a n/a
Quick Ratio 4.52 6.42 8.69 6.10 8.49 15.29 13.90 17.98
Current Ratio 4.52 5.53 4.10 6.04 8.49 15.29 13.90 17.98
Asset Turnover 0.11 0.08 0.24 0.10 0.07 0.03 0.01 n/a
Interest Coverage -170 -140 208.65 n/a n/a -11.15 n/a n/a
Return on Equity (ROE) -0.66 -0.41 0.06 -0.23 -0.46 -0.21 -0.34 -0.18
Return on Assets (ROA) -0.28 -0.2 0.03 -0.15 -0.37 -0.18 -0.28 -0.16
Return on Capital (ROIC) -0.37 -0.24 0.04 -0.19 -0.49 -0.21 -0.3 -0.17
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin -190.6% 87.50% 98.16% -105.12% -423.21% -494.35% -84.85% n/a
Net Profit Margin -262.39% -238.39% 13.84% -150.52% -506.21% -593.73% -3.76K% n/a
Pretax Profit Margin -257.26% -237.5% 14.27% -158.49% -564.73% -593.73% -3.76K% n/a
Operating Profit Margin -290.6% -250% 14.17% -160.27% -591.39% -656.76% -3.78K% n/a
FCF Margin -282.05% 380.36% -73.72% 139.47% -502.58% -559.55% -2.16K% n/a
EBITDA Margin -241.88% -223.21% 16.18% -152.83% -540.88% -612.89% -3.60K% n/a